成人肿瘤诊断流程图,必须收藏!

2016-07-21 主译:墨镜 审校:艾琳 美工:李宗恩 医学界肿瘤频道

BMJ公布的英国国家卫生与临床优化研究所(NICE)肿瘤诊断流程分为儿童&青少年和成人两部分。该流程图采用“思维导图”的形式,从症状入手、到对应的检查、再到疑似诊断,最后按病情的紧急程度进行处理,生动活泼地将严谨的肿瘤诊断过程呈现给各位小伙伴——成人癌症的可疑症状及处理

BMJ公布的英国国家卫生与临床优化研究所(NICE)肿瘤诊断流程分为儿童&青少年和成人两部分。该流程图采用“思维导图”的形式,从症状入手、到对应的检查、再到疑似诊断,最后按病情的紧急程度进行处理,生动活泼地将严谨的肿瘤诊断过程呈现给各位小伙伴——


成人癌症的可疑症状及处理








版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=913783, encodeId=2929913e831f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c55c5449391, createdName=mskeeplearning2021, createdTime=Tue Jan 05 07:52:41 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=96417, encodeId=28b69641e8f, content=明白了,唉╯▂╰, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5144754FFF2566.jpg, createdBy=04711932693, createdName=人生有信, createdTime=Sat Aug 06 11:15:00 CST 2016, time=2016-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532450, encodeId=675e15324502a, content=<a href='/topic/show?id=900e83101a4' target=_blank style='color:#2F92EE;'>#肿瘤诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83101, encryptionId=900e83101a4, topicName=肿瘤诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909612335511, createdName=lqvr, createdTime=Sat Jul 23 13:06:00 CST 2016, time=2016-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94266, encodeId=fdc99426621, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sat Jul 23 11:32:00 CST 2016, time=2016-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94131, encodeId=dd5e94131d0, content=学习学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Jul 22 13:46:00 CST 2016, time=2016-07-22, status=1, ipAttribution=)]
    2021-01-05 mskeeplearning2021

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=913783, encodeId=2929913e831f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c55c5449391, createdName=mskeeplearning2021, createdTime=Tue Jan 05 07:52:41 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=96417, encodeId=28b69641e8f, content=明白了,唉╯▂╰, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5144754FFF2566.jpg, createdBy=04711932693, createdName=人生有信, createdTime=Sat Aug 06 11:15:00 CST 2016, time=2016-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532450, encodeId=675e15324502a, content=<a href='/topic/show?id=900e83101a4' target=_blank style='color:#2F92EE;'>#肿瘤诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83101, encryptionId=900e83101a4, topicName=肿瘤诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909612335511, createdName=lqvr, createdTime=Sat Jul 23 13:06:00 CST 2016, time=2016-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94266, encodeId=fdc99426621, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sat Jul 23 11:32:00 CST 2016, time=2016-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94131, encodeId=dd5e94131d0, content=学习学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Jul 22 13:46:00 CST 2016, time=2016-07-22, status=1, ipAttribution=)]
    2016-08-06 人生有信

    明白了,唉╯▂╰

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=913783, encodeId=2929913e831f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c55c5449391, createdName=mskeeplearning2021, createdTime=Tue Jan 05 07:52:41 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=96417, encodeId=28b69641e8f, content=明白了,唉╯▂╰, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5144754FFF2566.jpg, createdBy=04711932693, createdName=人生有信, createdTime=Sat Aug 06 11:15:00 CST 2016, time=2016-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532450, encodeId=675e15324502a, content=<a href='/topic/show?id=900e83101a4' target=_blank style='color:#2F92EE;'>#肿瘤诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83101, encryptionId=900e83101a4, topicName=肿瘤诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909612335511, createdName=lqvr, createdTime=Sat Jul 23 13:06:00 CST 2016, time=2016-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94266, encodeId=fdc99426621, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sat Jul 23 11:32:00 CST 2016, time=2016-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94131, encodeId=dd5e94131d0, content=学习学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Jul 22 13:46:00 CST 2016, time=2016-07-22, status=1, ipAttribution=)]
    2016-07-23 lqvr
  4. [GetPortalCommentsPageByObjectIdResponse(id=913783, encodeId=2929913e831f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c55c5449391, createdName=mskeeplearning2021, createdTime=Tue Jan 05 07:52:41 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=96417, encodeId=28b69641e8f, content=明白了,唉╯▂╰, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5144754FFF2566.jpg, createdBy=04711932693, createdName=人生有信, createdTime=Sat Aug 06 11:15:00 CST 2016, time=2016-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532450, encodeId=675e15324502a, content=<a href='/topic/show?id=900e83101a4' target=_blank style='color:#2F92EE;'>#肿瘤诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83101, encryptionId=900e83101a4, topicName=肿瘤诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909612335511, createdName=lqvr, createdTime=Sat Jul 23 13:06:00 CST 2016, time=2016-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94266, encodeId=fdc99426621, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sat Jul 23 11:32:00 CST 2016, time=2016-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94131, encodeId=dd5e94131d0, content=学习学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Jul 22 13:46:00 CST 2016, time=2016-07-22, status=1, ipAttribution=)]
    2016-07-23 oo902

    好好学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=913783, encodeId=2929913e831f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c55c5449391, createdName=mskeeplearning2021, createdTime=Tue Jan 05 07:52:41 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=96417, encodeId=28b69641e8f, content=明白了,唉╯▂╰, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5144754FFF2566.jpg, createdBy=04711932693, createdName=人生有信, createdTime=Sat Aug 06 11:15:00 CST 2016, time=2016-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532450, encodeId=675e15324502a, content=<a href='/topic/show?id=900e83101a4' target=_blank style='color:#2F92EE;'>#肿瘤诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83101, encryptionId=900e83101a4, topicName=肿瘤诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=909612335511, createdName=lqvr, createdTime=Sat Jul 23 13:06:00 CST 2016, time=2016-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94266, encodeId=fdc99426621, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sat Jul 23 11:32:00 CST 2016, time=2016-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94131, encodeId=dd5e94131d0, content=学习学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Jul 22 13:46:00 CST 2016, time=2016-07-22, status=1, ipAttribution=)]
    2016-07-22 1dd8c52fm63(暂无匿称)

    学习学习!

    0

相关资讯

重磅! 首批肿瘤基因测序临床应用试点单位公布

2014年3月,国家卫生计生委医政医管局发布《关于开展高通量基因测序技术临床应用试点单位申报工作的通知》(以下简称通知)。《通知》指出已经开展高通量基因测序技术,且符合申报规定条件的医疗机构可以申请试点,并按照属地管理原则向所在省级卫生计生行政部门提交申报材料,同时明确申请试点的基因测序项目(如产前筛查和产前诊断、遗传病诊断、肿瘤诊断与治疗、植入前胚胎遗传学诊断等)。 2014年12月22日

非侵入式癌症诊断

新加坡的研究人员研发出一种于非侵入式胃癌检测的方法,利用一种指示癌症存在的mico-RNA,灵敏度超高。 2012年,世界范围内共有820万人死于癌症,这个数字预计2030年翻倍。其实,如果疾病能更早得到诊断,很多癌症死亡病例都可以避免。 为改善癌症检测状况,新加坡研究人员研发了一种非侵入式的肿瘤诊断方法,其实质是检测在基因表达调节起到重要作用的一类非编码RNA分子micro-RNA(miRN